Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies
ISTANBUL, Oct. 11, 2025 /PRNewswire/ — Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — today announced the introduction of its Easydrip™ Plus pen needles into the Turkish market through a leading regional diabetes distributor with a nationwide pharmacy network. The launch is already unlocking interest from neighbouring Middle‑East markets.
Key advantages
Market relevance
As the first pen needle with a patent‑protected hexagonal hub available in Turkey, Easydrip™ Plus is already attracting interest from neighbouring countries and sets a practical alternative between premium global brands and low‑end generics.
Availability & next steps
Certifications
Easydrip™ Plus is manufactured under a strict ISO 13485 quality system and holds CE Declaration of Conformity, meeting international safety and performance standards.
Brand Relationship
Sandstone Medical is SteriLance Medical’s diabetes‑care brand focused on self‑injection. Easydrip™ products are developed and marketed by Sandstone, with SteriLance providing manufacturing and quality systems under ISO 13485.
About Sandstone and SteriLance Medical
Sandstone designs patient‑centric solutions that make daily injections steadier and more comfortable. Founded in 1993, SteriLance Medical is a global innovator in blood‑sampling and injection solutions with 200+ patents and distribution in 50+ countries.
More information: en.sandstonemed.com | en.sterilance.com
Media & distribution enquiries: smu@sterilance.com
View original content:https://www.prnewswire.co.uk/news-releases/sandstone-easydrip-plus-pen-needles-debut-in-turkey–patentprotected-hexagonal-hub-for-comfort-and-control-302581334.html
RESTON, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Identity verification (IDV) is shifting from a…
Founded by longtime ServiceNow leaders from Thirdera, the firm launches with acquisitions and a strategic…
GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST)…
GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…
April 07, 2026 08:05 ET | Source: NextCure The U.S. Food and Drug Administration (FDA)…
April 07, 2026 08:00 ET | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE)…